Hepatic hydrothorax

Current Opinion in Pulmonary Medicine

Volumn 9, Issue 4, 2003, Pages 261-265

  Kinasewitz, Gary T ^a   Keddissi, Jean I ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

Ascites; Cirrhosis; Hepatic hydrothorax; Pleural effusion; Portal hypertension

Indexed keywords

FUROSEMIDE; SPIRONOLACTONE;

ASCITES; BIOSAFETY; CLINICAL FEATURE; DRUG EFFECT; HUMAN; HYDROTHORAX; LIVER DISEASE; LIVER TRANSPLANTATION; MICROSCOPY; PATHOPHYSIOLOGY; PLEURA EFFUSION; PLEURA FLUID; PORTOSYSTEMIC ANASTOMOSIS; REVIEW; THORACOCENTESIS; THORACOSCOPY; THORAX DRAINAGE;

HUMANS; HYDROTHORAX; HYPERTENSION, PORTAL; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; PARACENTESIS; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; RADIONUCLIDE IMAGING; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M SULFUR COLLOID; THORACOSCOPY;

EID: 0038338550     PISSN: 10705287     EISSN: None     Source Type: Journal    
DOI: 10.1097/00063198-200307000-00003     Document Type: Review

References (54)

1. Lieberman FL, Hidemura R, Peters RL, et al.: Pathogenesis and treatment of hydrothorax complicating cirrhosis with ascites. Ann Intern Med 1966, 64:341-351.
2. Johnston RF, Leo RV: Hepatic hydrothorax: studies to determine the source of the fluid and report of thirteen cases. Ann Intern Med 1964, 61:385-401.
3. Miksad R, de Ledinghen V, McDougall C, et al.: Hepatic hydrothorax associated with vitamin A toxicity. J Clin Gastroenterol 2002, 34:275-279. Portal hypertension in the absence of cirrhosis can give rise to a hepatic hydrothorax.
4. Mentes BB, Kayhan B, Gorgul A, et al.: Hepatic hydrothorax in the absence of ascites. Dig Dis Sci 1997, 42:781-788.
5. Hahn MH, Hahn PY, Gadallah SF, et al.: Hepatic hydrothorax: possible etiology of recurring pleural effusion. Am Fam Physician 1997, 56:523-527.
6. Wiener-Kronish JP, Matthay MA, Callen PW, et al.: Relationship of pleural effusions to pulmonary hemodynamics in patients with congestive heart failure. Am Rev Respir Dis 1985, 132:1253-1256.
7. Eid A, Keddissi JI, Kinasewitz GT: Hypoalbuminemia as a cause of pleural effusions. Chest 1999, 115:1066-1069.
8. Emerson PA: Hydrothorax complicating ascites. Lancet 1955, i:487-488.
9. Mouroux J, Hebuterne X, Perrin C, et al.: Treatment of pleural effusion of cirrhotic origin by videothoracoscopy. Br J Surg 1994, 81:546-547.
10. Lazaridis KN, Frank JW, Krowka MJ, et al.: Hepatic hydrothorax: pathogenesis, diagnosis, and management. Am J Med 1999, 107:262-267.
11. Rubinstein D, McInnes IE, Dudley FJ: Hepatic hydrothorax in the absence of clinical ascites: diagnosis and management. Gastroenterology 1985, 88:188-191.
12. Boz A, Cilli A, Yildiz A, et al.: The diagnosis of peritoneo-pleural communication with Tc-99m MAA scintigraphy in the absence of ascites. Clin Nucl Med 2000, 25:935-936.
13. Keddissi JI, Eid AA, Janbey EM, et al.: Incidence and outcome of hydrothorax in patients with chronic liver disease. Chest 2002, 122:94S. Recent series in which hepatic hydrothoraces tended to be small to moderate in size.
14. McVay PA, Toy PTCY: Lack of increased bleeding after paracentesis and thoracentesis in patients with mild coagulation abnormalities. Transfusion (Paris) 1991, 31:164-171.
15. Xiol X, Castellote J, Cortes-Beut R, et al.: Usefulness and complications of thoracentesis in cirrhotic patients. Am J Med 2001, 111:67-69.
16. Ackerman Z, Reynolds TB: Evaluation of pleural fluid in patients with cirrhosis. J Clin Gastroenterol 1997, 25:619-622.
17. Wang PS, Chen YM, Hsieh YL, et al.: Pleural effusion and serum soluble Fas-ligand levels are elevated in different clinical conditions. Lung 2003, 180:25-32. Elevated serum soluble Fas ligand levels distinguished patients with transudative pleural effusions resulting from viral cirrhosis from those with heart failure.
18. Valdes L, Alvarez D, Pose A, et al.: Cirrhosis of the liver, an exceptional cause of chylothorax: two cases. Respir Med 1996, 90:61-62.
19. Romero S, Martin C, Hernandez L, et al.: Chylothorax in cirrhosis of the liver: analysis of its frequency and clinical characteristics. Chest 1998, 114:154-159.
20. Xiol X, Castellote J, Baliellas C, et al.: Spontaneous bacterial empyema in cirrhotic patients: analysis of eleven cases. Hepatology 1990, 11:365-370.
21. Abba AA, Laajam MA, Zargar SA: Spontaneous neutrecytic hepatic hydrothorax without ascites. Respir Med 1996, 90:631-634.
22. Xiol X, Castellvi JM, Guardiola J, et al.: Spontaneous bacterial empyema in cirrhotic patients: a prospective study. Hepatology 1996, 23:709-723.
23. Wang JT, Fang CT, Hsueh PR, et al.: Spontaneous bacterial empyema caused by Aeromonas veronii biotype sobria. Diagn Microbial Infect Dis 2000, 37:271-273.
24. Behnia M, Clay AS, Hart CM: Enterococcus faecalis causing empyema in a patient with liver disease. South Med J 2002, 95:1201-1203. The pleural fluid was frankly purulent in this patient and required tube thoracostomy for resolution of the empyema.
25. Schuster DM, Mukundan S, Small W, et al.: The use of the diagnostic radionuclide ascites scan to facilitate treatment decisions for hepatic hydrothorax. Clin Nucl Med 1998, 23:16-18.
26. Eisenberg B, Velchik MG, Alavi A: Pleuroperitoneal communication in a patient with right pleural effusion and ascites diagnosed by technetium-99m sulfur colloid imaging. Clin Nucl Med 1988, 13:99-101.
27. Datta N, Mishkin FS, Vasinrapee P, et al.: Radionuclide demonstration of peritoneal-pleural communication as a cause for pleural fluid. JAMA 1984, 252:210.
28. Rajnish A, Sudhakar P: Diagnosis of hepatic hydrothorax by Tc-99m sulfur colloid peritoneal scintigraphy. Clin Nucl Med 2001, 26:888.
29. 99mTc sulfur colloid scintigraphic scanning.
30. Castellote J, Xiol X, Cortes-Beut R, et al.: Complications of thoracentesis in cirrhotic patients with pleural effusion. Rev Esp Enferm Dig 2001, 93:571-575. This prospective study noted complications that were rare after diagnostic taps, but pneumothorax occurred with increasing frequency after serial therapeutic taps.
31. Villena V, Lopez-Encuentra A, Pozo F, et al.: Measurement of pleural pressure during therapeutic thoracentesis. Am J Respir Crit Care Med 2000, 162:1534-1538.
32. Heller BJ, Grathwohl K: Contralateral reexpansion pulmonary edema. South Med J 2000, 93:828-831.
33. Angueira CE, Kadakia SO: Effects of large-volume paracentesis on pulmonary function in patients with tense cirrhotic ascites. Hepatology 1994, 20:825-828.
34. de Campos JRM, Andrade LO, Werebe ED, et al.: Hepatic hydrothorax. Semin Respir Crit Care Med 2001, 22:665-673. The authors review hepatic hydrothorax with an emphasis on therapy.
35. Runyon BA, Greenblatt M, Ming RHC: Hepatic hydrothorax is a relative contraindication to chest tube insertion. Am J Gastroenterol 1986, 81:566-567.
36. Chen A, Ho YS, Tu YC, et al.: Diaphragmatic defect as a cause of massive hydrothorax in cirrhosis of liver. J Clin Gastroenterol 1988, 10:663-666.
37. Falchuk KR, Jacoby I, Colucci WS, et al.: Tetracycline-induced pleural symphysis for recurrent hydrothorax complicating cirrhosis: a new approach to treatment. Gastroenterology 1977, 72:319-321.
38. Glazer M, Berkman N, Lafair JS, et al.: Successful talc slurry pleurodesis in patients with nonmalignant pleural effusion. Chest 2000, 117:1404-1409.
39. Conklin LD, Estrera AL, Weiner MA, et al.: Transjugular intrahepatic porto-systemic shunt for recurrent hepatic hydrothorax. Ann Thorac Surg 2000, 69:609-611.
40. Andrade RJ, Martin-Palanca AM, Fraile JM, et al.: Transjugular intrahepatic portosystemic shunt for the management of hepatic hydrothorax in the absence of ascites. J Clin Gastroenterol 1996, 22:305-307.
41. Siegerstetter V, Deibert P, Ochs A, et al.: Treatment of refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt: long-term results in 40 patients. Eur J Gastroenterol Hepatol 2001, 13:529-534. Largest series of patients with TIPS to manage hepatic hydrothorax noted improvement in 82% and resolution in 71%.
42. Ikard RW, Sawyers JL: Persistent hepatic hydrothorax after peritoneojugular shunt. Arch Surg 1980, 115:1125-1127.
43. Ferrante D, Arguedas MR, Cerfolio RJ, et al.: Video-assisted thoracoscopic surgery with talc pleurodesis in the management of symptomatic hepatic hydrothorax. Am J Gastroenterol 2002, 97:3172-3175. Video-assisted thoracoscopy was successful in 11 of 15 patients with hepatic hydrothorax, although six died and five others underwent liver transplantation within 6 months.
44. Strauss RM, Boyer TD: Hepatic hydrothorax. Semin Liver Dis 1997, 17:227-232.
45. Buchholz S, Kaplan V, Hauser M: Treatment of a right-sided pleural effusion in a patient with liver cirrhosis. Chest 2000, 117:248-250.
46. Gordon FD, Anastopoulos HT, Crenshaw W, et al.: The successful treatment of symptomatic, refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt. Hepatology 1997, 25:1366-1369.
47. Rosser BG, Poterucha JJ, McKusick MA, et al.: Thoracic duct-cutaneous fistula in a patient with cirrhosis of the liver: successful treatment with a transjugular intrahepatic portosystemic shunt. Mayo Clin Proc 1996, 71:793-796.
48. Rössle M: The transjugular intrahepatic portosystemic shunt. J Hepatol 1996, 25:224-231.
49. Vignaux O, Gouya H, Dousset B, et al.: Refractory chylothorax in hepatic cirrhosis: successful treatment by transjugular intrahepatic portosystemic shunt. J Thorac Imaging 2002, 17:233-236. TIPS can reduce thoracic duct lymph flow and facilitate chylothorax resolution in patients with portal hypertension.
50. Spencer EB, Cohen DT, Darcy MD: Safety and efficacy of transjugular intrahepatic portosystemic shunt creation for the treatment of hepatic hydrothorax. J Vasc Interv Radiol 2002, 13:385-390. TIPS controlled the hepatic hydrothorax in 74% of patients but four of five nonresponders died of multisystem organ failure within 30 days of the procedure.
51. Nunez O, Garcia A, Rincon D, et al.: Percutaneous intrahepatic portosystemic shunting as a treatment for refractory hepatic hydrothorax. Gastroenterol Hepatol 2002, 25:143-147. TIPS was successful in controlling refractory hepatic hydrothorax in four of five patients.
52. Mouroux J, Perrin C, Venissac N, et al.: Management of pleural effusion of cirrhotic origin. Chest 1996, 109:1093-1096.
53. de Campos JRM, Filho LOA, Werebe ED, et al.: Thoracoscopy and talc poudrage in the management of hepatic hydrothorax. Chest 2000, 118:13-17.
54. Vargas FS, Milanez JRC, Filomeno LTB, et al.: Intrapleural talc for the prevention of recurrence in benign or undiagnosed pleural effusions. Chest 1994, 106:1771-1775.